Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. EPA ordered to reassess glyphosate's impact on health, environment

Published 06/17/2022, 02:06 PM
Updated 06/17/2022, 05:27 PM
© Reuters. FILE PHOTO: Bayer's Roundup is shown for sale in Encinitas, California, U.S., June 26, 2017.  REUTERS/Mike Blake/File Photo

By Jonathan Stempel

(Reuters) - The U.S. Environmental Protection Agency was ordered by a federal appeals court on Friday to take a fresh look at whether glyphosate, the active ingredient in Bayer AG (ETR:BAYGN)'s Roundup weed killer, poses unreasonable risks to humans and the environment.

In a 3-0 decision, the 9th U.S. Circuit Court of Appeals agreed with several environmental, farmworker and food-safety advocacy groups that the EPA did not adequately consider whether glyphosate causes cancer and threatens endangered species.

The litigation began after the EPA reauthorized the use of glyphosate in January 2020.

Groups including the Natural Resources Defense Council, the Center for Food Safety and the Rural Coalition, which represents farmworkers, faulted the agency for rubber-stamping glyphosate despite its alleged harms to agriculture, farmers exposed during spraying, and wildlife such as the Monarch butterfly.

Circuit Judge Michelle Friedland wrote for the Pasadena, California-based appeals court that the EPA did not properly justify its findings that glyphosate did not threaten human health and was unlikely to be carcinogenic to humans. She also faulted aspects of the agency's approval process.

Bayer (OTC:BAYRY)'s Monsanto (NYSE:MON) unit, which makes Roundup, opposed groups challenging the EPA reauthorization. Friday's decision does not prevent people from using Roundup or similar products.

An EPA spokeswoman said the agency will review the decision.

Bayer said the EPA conducted a "rigorous assessment" of more than 40 years of science, and believes that the agency will continue to conclude that glyphosate-based herbicides are safe and are not carcinogenic.

George Kimbrell, legal director of the Center for Food Safety, which represented the Rural Coalition, in an interview called the decision "a historic victory for farmworkers, the public and endangered species."

Bayer has faced tens of thousands of lawsuits claiming that Roundup causes cancer and other illnesses.

© Reuters. FILE PHOTO: Bayer's Roundup is shown for sale in Encinitas, California, U.S., June 26, 2017.  REUTERS/Mike Blake/File Photo

The U.S. Supreme Court is expected to decide soon whether to hear the German company's appeal of a $25 million damages award to Edwin Hardeman, a Roundup user who blamed his cancer on its weedkillers.

The cases are Natural Resources Defense Council et al v EPA, 9th U.S. Circuit Court of Appeals, No. 20-70787, and Rural Coalition et al v EPA et al in the same court, No. 20-70801.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.